Ravicti OK'd for Lethal Urea Cycle Defects
(MedPage Today) -- The Food and Drug Administration has approved glycerol phenylbutyrate (Ravicti) for the treatment of the rare hereditary conditions known as urea cycle disorders.
Tags:
Ravicti OK'd for Lethal Urea Cycle Defects,
Food And Drug Administration Latest News